Literature DB >> 29128141

Intranasal fentanyl improves time to analgesic delivery in sickle cell pain crises.

Geoffrey S Kelly1, Rosalyn W Stewart2, John J Strouse3, Jennifer F Anders4.   

Abstract

Entities:  

Keywords:  Pain management; Pediatrics; Sickle cell disease; Vasooclusive event

Mesh:

Substances:

Year:  2017        PMID: 29128141     DOI: 10.1016/j.ajem.2017.11.015

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


× No keyword cloud information.
  5 in total

1.  [Use of rapid-onset fentanyl preparations beyond indication : A random questionnaire survey among congress participants and pain physicians].

Authors:  Stefan Wirz; Michael Schenk; Hannes Hofbauer; Hans-Christian Wartenberg; Marco Cascella; Kristin Kieselbach
Journal:  Schmerz       Date:  2020-09-25       Impact factor: 1.107

Review 2.  A Comprehensive Review of the Treatment and Management of Pain in Sickle Cell Disease.

Authors:  Jacob Fiocchi; Ivan Urits; Vwaire Orhurhu; Mariam Salisu Orhurhu; Stephen Giacomazzi; Briggs Hoyt; Alan D Kaye; Rachel J Kaye; Omar Viswanath
Journal:  Curr Pain Headache Rep       Date:  2020-03-21

3.  Emergency Department Provider Survey Regarding Acute Sickle Cell Pain Management.

Authors:  Olufunke Y Martin; Sean M Thompson; Aaron E Carroll; Seethal A Jacob
Journal:  J Pediatr Hematol Oncol       Date:  2020-08       Impact factor: 1.170

4.  A non-injected opioid analgesia protocol for acute pain crisis in adolescents and adults with sickle cell disease.

Authors:  Paul Telfer; Jonathan Bestwick; James Elander; Arlene Osias; Nosheen Khalid; Imogen Skene; Ruben Nzouakou; Joanne Challands; Filipa Barroso; Banu Kaya
Journal:  Br J Pain       Date:  2021-08-02

5.  Analgesic management of uncomplicated acute sickle-cell pain crisis in pediatrics: a systematic review and meta-analysis.

Authors:  Manou Irmina Saramba; Sandeep Shakya; Dongchi Zhao
Journal:  J Pediatr (Rio J)       Date:  2019-07-24       Impact factor: 2.990

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.